3
|
van Houdt PJ, Kallehauge JF, Tanderup K, Nout R, Zaletelj M, Tadic T, van Kesteren ZJ, van den Berg CAT, Georg D, Côté JC, Levesque IR, Swamidas J, Malinen E, Telliskivi S, Brynolfsson P, Mahmood F, van der Heide UA. Phantom-based quality assurance for multicenter quantitative MRI in locally advanced cervical cancer. Radiother Oncol 2020; 153:114-121. [PMID: 32931890 DOI: 10.1016/j.radonc.2020.09.013] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2020] [Revised: 09/07/2020] [Accepted: 09/08/2020] [Indexed: 02/08/2023]
Abstract
BACKGROUND AND PURPOSE A wide variation of MRI systems is a challenge in multicenter imaging biomarker studies as it adds variation in quantitative MRI values. The aim of this study was to design and test a quality assurance (QA) framework based on phantom measurements, for the quantitative MRI protocols of a multicenter imaging biomarker trial of locally advanced cervical cancer. MATERIALS AND METHODS Fifteen institutes participated (five 1.5 T and ten 3 T scanners). Each institute optimized protocols for T2, diffusion-weighted imaging, T1, and dynamic contrast-enhanced (DCE-)MRI according to system possibilities, institutional preferences and study-specific constraints. Calibration phantoms with known values were used for validation. Benchmark protocols, similar on all systems, were used to investigate whether differences resulted from variations in institutional protocols or from system variations. Bias, repeatability (%RC), and reproducibility (%RDC) were determined. Ratios were used for T2 and T1 values. RESULTS The institutional protocols showed a range in bias of 0.88-0.98 for T2 (median %RC = 1%; %RDC = 12%), -0.007 to 0.029 × 10-3 mm2/s for the apparent diffusion coefficient (median %RC = 3%; %RDC = 18%), and 0.39-1.29 for T1 (median %RC = 1%; %RDC = 33%). For DCE a nonlinear vendor-specific relation was observed between measured and true concentrations with magnitude data, whereas the relation was linear when phase data was used. CONCLUSION We designed a QA framework for quantitative MRI protocols and demonstrated for a multicenter trial for cervical cancer that measurement of consistent T2 and apparent diffusion coefficient values is feasible despite protocol differences. For DCE-MRI and T1 mapping with the variable flip angle method, this was more challenging.
Collapse
Affiliation(s)
- Petra J van Houdt
- Department of Radiation Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
| | | | - Kari Tanderup
- Department of Clinical Medicine, Aarhus University Hospital, Denmark
| | - Remi Nout
- Department of Radiation Oncology, Leiden University Medical Center, the Netherlands
| | - Marko Zaletelj
- Department of Radiotherapy, Institute of Oncology Ljubljana, Slovenia
| | - Tony Tadic
- Radiation Medicine Program, Princess Margaret Cancer Center, Toronto, Canada
| | - Zdenko J van Kesteren
- Department of Radiation Oncology, Amsterdam University Medical Center, the Netherlands
| | | | - Dietmar Georg
- Division of Medical Radiation Physics, Department of Radiation Oncology, Medical University Of Vienna, Austria
| | - Jean-Charles Côté
- Department of Radiation Oncology, Centre Hospitalier de l'Universite de Montreal, Canada
| | - Ives R Levesque
- Medical Physics Unit and Gerald Bronfman Department of Oncology, McGill University, Montreal, Canada
| | - Jamema Swamidas
- Department of Radiation Oncology, Tata Memorial Centre, Mumbai, India
| | - Eirik Malinen
- Department of Medical Physics, Oslo University Hospital, Norway
| | - Sven Telliskivi
- Department of Radiation Oncology, North-Estonia Medical Centre, Tallinn, Estonia
| | - Patrik Brynolfsson
- Department of Translational Sciences, Skåne University Hospital, Lund, Sweden
| | - Faisal Mahmood
- Department of Oncology, Odense University Hospital, Denmark; Department of Clinical Research, University of Southern Denmark, Odense, Denmark
| | - Uulke A van der Heide
- Department of Radiation Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands
| | | |
Collapse
|
7
|
You SH, Choi SH, Kim TM, Park CK, Park SH, Won JK, Kim IH, Lee ST, Choi HJ, Yoo RE, Kang KM, Yun TJ, Kim JH, Sohn CH. Differentiation of High-Grade from Low-Grade Astrocytoma: Improvement in Diagnostic Accuracy and Reliability of Pharmacokinetic Parameters from DCE MR Imaging by Using Arterial Input Functions Obtained from DSC MR Imaging. Radiology 2017; 286:981-991. [PMID: 29244617 DOI: 10.1148/radiol.2017170764] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Purpose To evaluate whether arterial input functions (AIFs) derived from dynamic susceptibility-contrast (DSC) magnetic resonance (MR) imaging, or AIFDSC values, improve diagnostic accuracy and reliability of the pharmacokinetic (PK) parameters of dynamic contrast material-enhanced (DCE) MR imaging for differentiating high-grade from low-grade astrocytomas, compared with AIFs obtained from DCE MR imaging (AIFDCE). Materials and Methods This retrospective study included 226 patients (138 men, 88 women; mean age, 52.27 years ± 15.17; range, 24-84 years) with pathologically confirmed astrocytomas (World Health Organization grade II = 21, III = 53, IV = 152; isocitrate dehydrogenase mutant, 11.95% [27 of 226]; 1p19q codeletion 0% [0 of 226]). All patients underwent both DSC and DCE MR imaging before surgery, and AIFDSC and AIFDCE were obtained from each image. Volume transfer constant (Ktrans), volume of vascular plasma space (vp), and volume of extravascular extracellular space (ve) were processed by using postprocessing software with two AIFs. The diagnostic accuracies of individual parameters were compared by using receiver operating characteristic curve (ROC) analysis. Intraclass correlation coefficients (ICCs) and the Bland-Altman method were used to assess reliability. Results The AIFDSC-driven mean Ktrans and ve were more accurate for differentiating high-grade from low-grade astrocytoma than those derived by using AIFDCE (area under the ROC curve: mean Ktrans, 0.796 vs 0.645, P = .038; mean ve, 0.794 vs 0.658, P = .020). All three parameters had better ICCs with AIFDSC than with AIFDCE (Ktrans, 0.737 vs 0.095; vp, 0.848 vs 0.728; ve, 0.875 vs 0.581, respectively). In AIF analysis, maximal signal intensity (0.837 vs 0.524) and wash-in slope (0.800 vs 0.432) demonstrated better ICCs with AIFDSC than AIFDCE. Conclusion AIFDSC-driven DCE MR imaging PK parameters showed better diagnostic accuracy and reliability for differentiating high-grade from low-grade astrocytoma than those derived from AIFDCE. © RSNA, 2017 Online supplemental material is available for this article.
Collapse
Affiliation(s)
- Sung-Hye You
- From the Department of Radiology (S.H.Y., S.H.C., H.J.C., R.E.Y., K.M.K., T.J.Y., J.H.K., C.H.S.), Department of Internal Medicine (T.M.K.), Department of Radiation Oncology (I.H.K.), Cancer Research Institute, Department of Neurosurgery, Biomedical Research Institute (C.K.P.), Department of Pathology (S.H.P., J.K.W.) and Department of Neurology (S.T.L.), Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, 110-744 Seoul, Korea; Center for Nanoparticle Research, Institute for Basic Science (S.H.C.), and School of Chemical and Biological Engineering (S.H.C.), Seoul National University, Seoul, Korea
| | - Seung Hong Choi
- From the Department of Radiology (S.H.Y., S.H.C., H.J.C., R.E.Y., K.M.K., T.J.Y., J.H.K., C.H.S.), Department of Internal Medicine (T.M.K.), Department of Radiation Oncology (I.H.K.), Cancer Research Institute, Department of Neurosurgery, Biomedical Research Institute (C.K.P.), Department of Pathology (S.H.P., J.K.W.) and Department of Neurology (S.T.L.), Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, 110-744 Seoul, Korea; Center for Nanoparticle Research, Institute for Basic Science (S.H.C.), and School of Chemical and Biological Engineering (S.H.C.), Seoul National University, Seoul, Korea
| | - Tae Min Kim
- From the Department of Radiology (S.H.Y., S.H.C., H.J.C., R.E.Y., K.M.K., T.J.Y., J.H.K., C.H.S.), Department of Internal Medicine (T.M.K.), Department of Radiation Oncology (I.H.K.), Cancer Research Institute, Department of Neurosurgery, Biomedical Research Institute (C.K.P.), Department of Pathology (S.H.P., J.K.W.) and Department of Neurology (S.T.L.), Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, 110-744 Seoul, Korea; Center for Nanoparticle Research, Institute for Basic Science (S.H.C.), and School of Chemical and Biological Engineering (S.H.C.), Seoul National University, Seoul, Korea
| | - Chul-Kee Park
- From the Department of Radiology (S.H.Y., S.H.C., H.J.C., R.E.Y., K.M.K., T.J.Y., J.H.K., C.H.S.), Department of Internal Medicine (T.M.K.), Department of Radiation Oncology (I.H.K.), Cancer Research Institute, Department of Neurosurgery, Biomedical Research Institute (C.K.P.), Department of Pathology (S.H.P., J.K.W.) and Department of Neurology (S.T.L.), Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, 110-744 Seoul, Korea; Center for Nanoparticle Research, Institute for Basic Science (S.H.C.), and School of Chemical and Biological Engineering (S.H.C.), Seoul National University, Seoul, Korea
| | - Sung-Hye Park
- From the Department of Radiology (S.H.Y., S.H.C., H.J.C., R.E.Y., K.M.K., T.J.Y., J.H.K., C.H.S.), Department of Internal Medicine (T.M.K.), Department of Radiation Oncology (I.H.K.), Cancer Research Institute, Department of Neurosurgery, Biomedical Research Institute (C.K.P.), Department of Pathology (S.H.P., J.K.W.) and Department of Neurology (S.T.L.), Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, 110-744 Seoul, Korea; Center for Nanoparticle Research, Institute for Basic Science (S.H.C.), and School of Chemical and Biological Engineering (S.H.C.), Seoul National University, Seoul, Korea
| | - Jae-Kyung Won
- From the Department of Radiology (S.H.Y., S.H.C., H.J.C., R.E.Y., K.M.K., T.J.Y., J.H.K., C.H.S.), Department of Internal Medicine (T.M.K.), Department of Radiation Oncology (I.H.K.), Cancer Research Institute, Department of Neurosurgery, Biomedical Research Institute (C.K.P.), Department of Pathology (S.H.P., J.K.W.) and Department of Neurology (S.T.L.), Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, 110-744 Seoul, Korea; Center for Nanoparticle Research, Institute for Basic Science (S.H.C.), and School of Chemical and Biological Engineering (S.H.C.), Seoul National University, Seoul, Korea
| | - Il Han Kim
- From the Department of Radiology (S.H.Y., S.H.C., H.J.C., R.E.Y., K.M.K., T.J.Y., J.H.K., C.H.S.), Department of Internal Medicine (T.M.K.), Department of Radiation Oncology (I.H.K.), Cancer Research Institute, Department of Neurosurgery, Biomedical Research Institute (C.K.P.), Department of Pathology (S.H.P., J.K.W.) and Department of Neurology (S.T.L.), Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, 110-744 Seoul, Korea; Center for Nanoparticle Research, Institute for Basic Science (S.H.C.), and School of Chemical and Biological Engineering (S.H.C.), Seoul National University, Seoul, Korea
| | - Soon Tae Lee
- From the Department of Radiology (S.H.Y., S.H.C., H.J.C., R.E.Y., K.M.K., T.J.Y., J.H.K., C.H.S.), Department of Internal Medicine (T.M.K.), Department of Radiation Oncology (I.H.K.), Cancer Research Institute, Department of Neurosurgery, Biomedical Research Institute (C.K.P.), Department of Pathology (S.H.P., J.K.W.) and Department of Neurology (S.T.L.), Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, 110-744 Seoul, Korea; Center for Nanoparticle Research, Institute for Basic Science (S.H.C.), and School of Chemical and Biological Engineering (S.H.C.), Seoul National University, Seoul, Korea
| | - Hye Jeong Choi
- From the Department of Radiology (S.H.Y., S.H.C., H.J.C., R.E.Y., K.M.K., T.J.Y., J.H.K., C.H.S.), Department of Internal Medicine (T.M.K.), Department of Radiation Oncology (I.H.K.), Cancer Research Institute, Department of Neurosurgery, Biomedical Research Institute (C.K.P.), Department of Pathology (S.H.P., J.K.W.) and Department of Neurology (S.T.L.), Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, 110-744 Seoul, Korea; Center for Nanoparticle Research, Institute for Basic Science (S.H.C.), and School of Chemical and Biological Engineering (S.H.C.), Seoul National University, Seoul, Korea
| | - Roh-Eul Yoo
- From the Department of Radiology (S.H.Y., S.H.C., H.J.C., R.E.Y., K.M.K., T.J.Y., J.H.K., C.H.S.), Department of Internal Medicine (T.M.K.), Department of Radiation Oncology (I.H.K.), Cancer Research Institute, Department of Neurosurgery, Biomedical Research Institute (C.K.P.), Department of Pathology (S.H.P., J.K.W.) and Department of Neurology (S.T.L.), Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, 110-744 Seoul, Korea; Center for Nanoparticle Research, Institute for Basic Science (S.H.C.), and School of Chemical and Biological Engineering (S.H.C.), Seoul National University, Seoul, Korea
| | - Koung Mi Kang
- From the Department of Radiology (S.H.Y., S.H.C., H.J.C., R.E.Y., K.M.K., T.J.Y., J.H.K., C.H.S.), Department of Internal Medicine (T.M.K.), Department of Radiation Oncology (I.H.K.), Cancer Research Institute, Department of Neurosurgery, Biomedical Research Institute (C.K.P.), Department of Pathology (S.H.P., J.K.W.) and Department of Neurology (S.T.L.), Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, 110-744 Seoul, Korea; Center for Nanoparticle Research, Institute for Basic Science (S.H.C.), and School of Chemical and Biological Engineering (S.H.C.), Seoul National University, Seoul, Korea
| | - Tae Jin Yun
- From the Department of Radiology (S.H.Y., S.H.C., H.J.C., R.E.Y., K.M.K., T.J.Y., J.H.K., C.H.S.), Department of Internal Medicine (T.M.K.), Department of Radiation Oncology (I.H.K.), Cancer Research Institute, Department of Neurosurgery, Biomedical Research Institute (C.K.P.), Department of Pathology (S.H.P., J.K.W.) and Department of Neurology (S.T.L.), Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, 110-744 Seoul, Korea; Center for Nanoparticle Research, Institute for Basic Science (S.H.C.), and School of Chemical and Biological Engineering (S.H.C.), Seoul National University, Seoul, Korea
| | - Ji-Hoon Kim
- From the Department of Radiology (S.H.Y., S.H.C., H.J.C., R.E.Y., K.M.K., T.J.Y., J.H.K., C.H.S.), Department of Internal Medicine (T.M.K.), Department of Radiation Oncology (I.H.K.), Cancer Research Institute, Department of Neurosurgery, Biomedical Research Institute (C.K.P.), Department of Pathology (S.H.P., J.K.W.) and Department of Neurology (S.T.L.), Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, 110-744 Seoul, Korea; Center for Nanoparticle Research, Institute for Basic Science (S.H.C.), and School of Chemical and Biological Engineering (S.H.C.), Seoul National University, Seoul, Korea
| | - Chul-Ho Sohn
- From the Department of Radiology (S.H.Y., S.H.C., H.J.C., R.E.Y., K.M.K., T.J.Y., J.H.K., C.H.S.), Department of Internal Medicine (T.M.K.), Department of Radiation Oncology (I.H.K.), Cancer Research Institute, Department of Neurosurgery, Biomedical Research Institute (C.K.P.), Department of Pathology (S.H.P., J.K.W.) and Department of Neurology (S.T.L.), Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, 110-744 Seoul, Korea; Center for Nanoparticle Research, Institute for Basic Science (S.H.C.), and School of Chemical and Biological Engineering (S.H.C.), Seoul National University, Seoul, Korea
| |
Collapse
|
10
|
Hectors SJ, Besa C, Wagner M, Jajamovich GH, Haines GK, Lewis S, Tewari A, Rastinehad A, Huang W, Taouli B. DCE-MRI of the prostate using shutter-speed vs. Tofts model for tumor characterization and assessment of aggressiveness. J Magn Reson Imaging 2017; 46:837-849. [PMID: 28092414 DOI: 10.1002/jmri.25631] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2016] [Accepted: 12/27/2016] [Indexed: 01/10/2023] Open
Abstract
PURPOSE To quantify Tofts model (TM) and shutter-speed model (SSM) perfusion parameters in prostate cancer (PCa) and noncancerous peripheral zone (PZ) and to compare the diagnostic performance of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to Prostate Imaging and Reporting and Data System (PI-RADS) classification for the assessment of PCa aggressiveness. MATERIALS AND METHODS Fifty PCa patients (mean age 60 years old) who underwent MRI at 3.0T followed by prostatectomy were included in this Institutional Review Board-approved retrospective study. DCE-MRI parameters (Ktrans , ve , kep [TM&SSM] and intracellular water molecule lifetime τi [SSM]) were determined in PCa and PZ. Differences in DCE-MRI parameters between PCa and PZ, and between models were assessed using Wilcoxon signed-rank tests. Receiver operating characteristic (ROC) analysis for differentiation between PCa and PZ was performed for individual and combined DCE-MRI parameters. Diagnostic performance of DCE-MRI parameters for identification of aggressive PCa (Gleason ≥8, grade group [GG] ≥3 or pathology stage pT3) was assessed using ROC analysis and compared with PI-RADSv2 scores. RESULTS DCE-MRI parameters were significantly different between TM and SSM and between PZ and PCa (P < 0.037). Diagnostic performances of TM and SSM for differentiation of PCa from PZ were similar (highest AUC TM: Ktrans +kep 0.76, SSM: τi +kep 0.80). PI-RADS outperformed TM and SSM DCE-MRI for identification of Gleason ≥8 lesions (AUC PI-RADS: 0.91, highest AUC DCE-MRI: Ktrans +τi SSM 0.61, P = 0.002). The diagnostic performance of PI-RADS and DCE-MRI for identification of GG ≥3 and pT3 PCa was not significantly different (P > 0.213). CONCLUSION SSM DCE-MRI did not increase the diagnostic performance of DCE-MRI for PCa characterization. PI-RADS outperformed both TM and SSM DCE-MRI for identification of aggressive cancer. LEVEL OF EVIDENCE 3 Technical Efficacy: Stage 2 J. MAGN. RESON. IMAGING 2017;46:837-849.
Collapse
Affiliation(s)
- Stefanie J Hectors
- Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Cecilia Besa
- Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.,Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Mathilde Wagner
- Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Guido H Jajamovich
- Applied Mathematics and Modeling, Scientific Informatics Department, Merck Sharp & Dohme, Boston, Massachusetts, USA
| | - George K Haines
- Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Sara Lewis
- Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.,Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Ashutosh Tewari
- Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Ardeshir Rastinehad
- Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Wei Huang
- Advanced Imaging Research Center, Oregon Health & Science University, Portland, Oregon, USA
| | - Bachir Taouli
- Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.,Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| |
Collapse
|